As part of an accelerated approval process, the Mumbai-based pharmaceutical company gained manufacturing-marketing authorisation for Nitric Oxide Nasal Spray from…
Glenmark Pharmaceuticals announced on Monday that the country's health regulator has given its generic Regadenoson injectable preliminary approval. The regadenoson…
Glenmark Pharmaceuticals has announced today the successful conclusion of its Favipiravir (FabiFlu®) post marketing surveillance (PMS) in India study, which…
On Monday, Glenmark Pharmaceuticals announced an exclusive long-term strategic relationship with SaNOtize Research, a Canadian biotech startup, to produce, market,…
Glenmark Pharmaceuticals yesterday said it has received approval from the US health regulator to market Nintedanib capsules, used in the…
Glenmark Pharmaceuticals Ltd has received tentative approval by the United States Food and Drug Administration (USFDA) for Nentenab Capsules, 100…
Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva,…
Glenmark Pharmaceuticals announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India. The…
Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline…
Glenmark Pharmaceuticals has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel Tablets, 200 mg…